Barely Significant
← all excerpts

Interactions between key genes and pathways in prostate cancer progression and therapy resistance.

Front Oncol · 2025 · PMC11799259 · PMID 39917165

Europe PMCDOI
1
hedged sentence
0.0664
closest p · 1.3× alpha
0.0664
boldest claim

The sentences

did not reach statistical significanceP=0.0664so close (0.05 < p ≤ 0.1)
In breast cancer, data from the latest MONARCH-3 study showed that at a median follow-up time of 8.1 years, treatment with Abemaciclib in combination with an nonsteroidal aromatase inhibitor (NSAI) numerically prolonged Overall Survival (OS) compared to NSAI therapy alone in patients with HR+, HER2- advanced breast cancer, however, unfortunately, the difference did not reach statistical significance (P=0.0664) ( 47 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.